Lasers in the era of evidence-based medicine

References

• Salvatore S, Maggiore ULR, Athanasiou S, et al. Histological study on the effects of microablative fractional CO2 laser on atrophic vaginal tissue: an ex vivo study. Menopause 2015;22:845–9
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M, Cervigni M. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of the menopause. Climacteric 2015;18:757–63
   PubMed Web of Science ®Google Scholar
• Tadir Y, Gaspar A, Lev-Sagie A, et al. Light and energy based therapeutics for genitourinary syndrome of menopause: consensus and controversies. Lasers Surg Med 2017;49:137–59
   PubMed Web of Science ®Google Scholar
• Preti M, Vieira-Baptista P, Digesu G, et al. The clinical role of LASER for vulvar and vaginal treatments in Gynecology and Female Urology: an ICS/ISSVD best practice consensus document. J Low Genit Tract Dis 2019;23:151–60
   PubMed Web of Science ®Google Scholar
• Abbas Shobeiri S, Kerkhof MH, Minassian VA, et al. IUGA Committee opinion: laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Int Urogynecol J 2019;30:371–6
   PubMed Web of Science ®Google Scholar
• Pitsouni E, Grigoriadis T, Tsiveleka A, et al. Microablative fractional CO2-laser therapy and the genitourinary syndrome of menopause: an observational study. Maturitas 2016;94:131–6
   PubMed Web of Science ®Google Scholar
• Siliquini GP, Tuninetti V, Bounous VE, et al. Fractional CO2 laser therapy: a new challenge for vulvovaginal atrophy in postmenopausal women. Climacteric 2017;20:379–84
   PubMed Web of Science ®Google Scholar
• Sokol ER, Karram MM. An assessment of the safety and efficacy of a CO2 laser system for the treatment of vulvovaginal atrophy. Menopause 2016;23:1102–7
   PubMed Web of Science ®Google Scholar
• Sokol ER, Karram MM. Use of a novel fractional CO2 laser for the treatment of genitourinary syndrome of menopause: 1-year outcomes. Menopause 2017;24:810–14
   PubMed Web of Science ®Google Scholar
• Gaspar A, Brandi H, Gomez V, Luque D. Efficacy of Erbium:YAG laser treatment compared to topical estriol treatment for symptoms of genitourinary syndrome of menopause. Lasers Surg Med 2017;49:160–8
   PubMed Web of Science ®Google Scholar
• Behnia-Willison F, Sarraf S, Miller J, et al. Safety and long-term efficacy of fractional CO2 laser treatment in women suffering from genitourinary syndrome of menopause. Eur J Obstet Gynecol Reprod Biol 2017;213:39–44
   PubMed Web of Science ®Google Scholar
• Pieralli A, Bianchi C, Longinotti M, et al. Long-term reliability of fractioned CO2 laser as a treatment for vulvovaginal atrophy. Arch Gynecol Obstet 2017;296:973–8
   PubMed Web of Science ®Google Scholar
• Cruz VL, Steiner ML, Pompei LM, et al. Randomized double-blind placebo controlled clinical trial for evaluating the efficacy of fractional CO2 laser compared with topical estriol in the treatment of vaginal atrophy in postmenopausal women. Menopause 2018;25:21–8
   PubMed Web of Science ®Google Scholar
• Paraiso MF, Ferrando CA, Sokol ER, et al. A randomized clinical trial comparing vaginal laser therapy to vaginal estrogen therapy in women with genitourinary syndrome of menopause: the VeLVET Trial. Menopause 2020;27:50–6
   PubMed Web of Science ®Google Scholar
• Filippini M, Luvero D, Salvatore S, et al. Efficacy of fractional CO2 laser treatment in postmenopausal women with genitourinary syndrome: a multicenter study. Menopause 2020;27:43–9
   PubMed Web of Science ®Google Scholar
• Politano CA, Costa-Palva L, Aguiar LB, et al. Fractional CO2 laser versus promestriene and lubricant in genitourinary syndrome of menopause: a randomized clinical trial. Menopause 2019;26:833–40
   PubMed Web of Science ®Google Scholar
• Phillips C, Hillard TC, Salvatore S, et al. Lasers in gynaecology. Eur J Obstet Gynecol 2020;213:39–44
   Google Scholar
• Pitsouni E, Grigoriadis T, Falagas ME, et al. Laser therapy for genitourinary syndrome of the menopause. A systematic review and meta-analysis. Maturitas 2017;103:78–88
   PubMed Web of Science ®Google Scholar
• Arunkalaivanan A, Kaur H, Onuma O. Laser therapy as a treatment modality for genitourinary syndrome of menopause: a critical appraisal of evidence. Int Urogynecol J 2017;28:681–5
   PubMed Web of Science ®Google Scholar
• Jha S, Hillard T. Energy devices in vaginal therapy. Obstet Gynecol 2019;21:233–6
   Google Scholar
• Baber RJ, Panay N, Fenton A. 2016 IMS Recommendations on women’s midlife health and menopause hormone therapy. Climacteric 2016;19:109–50
   PubMed Web of Science ®Google Scholar
• Shrifren JL, Gass M. The North American menopause society recommendations for clinical care of midlife women. Menopause 2014;21:1038–62
   PubMed Web of Science ®Google Scholar
• Athanasiou S, Pitsouni E, Falagas ME, et al. CO2 laser for genitourinary syndrome of the menopause. How many laser sessions? Maturitas 2017;104:24–8
   PubMed Web of Science ®Google Scholar
• Available from: https://www.fda.gov/medical-devices/safety-communications/fda-warns-against-use-energy-based-devices-perform-vaginal-rejuvenation-or-vaginal-cosmetic [last accessed 27 May 2020]
   Google Scholar
• Ahluwalia J, Avram MM, Ortiz AE. Lasers and energy-based devices marketed for vaginal rejuvenation: a cross-sectional analysis of the MAUDE database. Lasers Surg Med 2019;51:671–7
   PubMed Web of Science ®Google Scholar
• Gordon C, Gonzales S, Krychman ML. Rethinking the techno vagina: a case series of patient complications following vaginal laser treatment for atrophy. Menopause 2019;26:423–7
   PubMed Web of Science ®Google Scholar
• Flint R, Cardozo L, Grigoriadis T, et al. Rationale and design for fractional microablative CO2 laser versus photothermal non-ablative erbium: YAG laser for the management of genitourinary syndrome of menopause: a non-inferiority, single-blind randomized controlled trial. Climacteric 2019;22:307–11
   PubMed Web of Science ®Google Scholar
• Jha S, Wyld L, Krishnaswamy PH. The impact of vaginal laser treatment for genito-urinary syndrome of the menopause in breast cancer survivors: a systematic review and meta-analysis. Clin Breast Cancer 2019;19:556–62
   PubMed Web of Science ®Google Scholar
• Pagano T, De Rosa P, Vallone R, et al. Fractional microablative CO2 laser for vulvovaginal atrophy in women treated with chemotherapy and/or hormonal therapy for breast cancer: a retrospective study. Menopause 2016;23:1108–13
   PubMed Web of Science ®Google Scholar
• Bojanini J. Treatment of genitourinary syndrome of menopause with Erbium:YAG laser: a prospective study of efficacy and safety of the treatment for women after menopause of natural origin and therapy-induced menopause in breast cancer survivors. J Laser Health Acad 2016;1:35–40
   Google Scholar
• Pieralli A, Fallani MG, Becorpi A, et al. Fractional CO2 laser for vulvovaginal atrophy (VVA) dyspareunia relief in breast cancer survivors. Arch Gynecol Obstet 2016;294:841–6
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Menopause 2017;24:316–19
   PubMed Web of Science ®Google Scholar
• Pearson A, Booker A, Tio M, Marx G. Vaginal CO2 laser for the treatment of vulvovaginal atrophy in women with breast cancer: LAAVA pilot study. Breast Cancer Res Treat 2019;178:135–40
   PubMed Web of Science ®Google Scholar
• Isaza PG, Jaguszewska K, Cardona JL, Lukaszuk M. Long-term effect of thermoablative fractional CO2 laser treatment as a novel approach to urinary incontinence management in women with genitourinary syndrome of menopause. Int Urogynecol J 2018;29:211–15
   PubMed Web of Science ®Google Scholar
• Gambacciani M, Levancini M, Russo E, et al. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Climacteric 2018;21:148–5
   PubMed Web of Science ®Google Scholar
• Okui N. Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. World J Urol 2019;37:885–9
   PubMed Web of Science ®Google Scholar
• NICE guidance NG 23. Urinary incontinence and pelvic organ prolapse in women: management. 2019. Available from: https://www.nice.org.uk/guidance/ng123 [last accessed 27 May 2020]
   Google Scholar
• Serati M, Mancini V, Balzarro M. Urethral bulking agents for the treatment of female stress urinary incontinence. Int J UroGynecol 2020;30:1413–17
   Web of Science ®Google Scholar
• VESPER: Stress Urinary Incontinence (VESPER-SUI). Available from: https://clinicaltrials.gov/ct2/show/NCT03996070 [last accessed 27 May 2012]
   Google Scholar
• The efficacy and safety of FotonaSmooth® Device for treatment of stress urinary incontinence. Available from: https://clinicaltrials.gov/ct2/show/NCT03098992 [last accessed 27 May 2012]
   Google Scholar
• Bizjak-Ogrinc U, Sencar S. Non-ablative vaginal erbium YAG laser for the treatment of cystocele. Ital J Gynaecol Obstet 2017;29:19–25
   Google Scholar
• Bizjak-Ogrinc U, Sencar S, Vizintin Z. 3 years follow-up of pelvic organ prolapses treated with Er:YAG laser. Lasers Surg Med 2017;49:63
   PubMed Web of Science ®Google Scholar
• VESPER: Pelvic Organ Prolapse Study (VESPER:POP). Available from: https://clinicaltrials.gov/ct2/show/NCT03995797?term=VESPER&draw=2&rank=1 [last accessed 27 May 2012]
   Google Scholar
• Lin YH, Hsieh WC, Huang L, Liang CC. Effect of non-ablative laser treatment on overactive bladder symptoms, urinary incontinence and sexual function in women with urodynamic stress incontinence. Taiwan J Obstet Gynecol 2017;56:815–20
   PubMed Web of Science ®Google Scholar
• Perino A, Cucinella G, Gugliotta G, et al. Is vaginal fractional CO2 laser treatment effective in improving overactive bladder symptoms in post-menopausal patients? Preliminary results. Eur Rev Med Pharmacol Sci 2016;20:2491–7
   PubMed Web of Science ®Google Scholar
• Okui N. Efficacy and safety of non-ablative vaginal erbium: YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: comparison with anticholinergics and β3-adrenoceptor agonists. World J Urol 2019;37:2459–66
   PubMed Web of Science ®Google Scholar
• Bizjak Ogrinc U, Senčar S, Luzar B, Lukanović A. Efficacy of non-ablative laser therapy for lichen sclerosus: a randomized controlled trial. J Obstet Gynaecol Can 2019;41:1717–25
   PubMed Web of Science ®Google Scholar
• Gómez-Frieiro M, Laynez-Herrero E. Use of Er:YAG laser in the treatment of vulvar lichen sclerosus. Int J Womens Dermatol 2019;5:340–4
   PubMedGoogle Scholar